Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, today announced ...

A team of researchers, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute), explored the ...

In a rodent model of T2D, icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with ...

Scientists at Cold Spring Harbor Laboratory have cracked open the secrets of plant stem cells, mapping key genetic regulators in maize and Arabidopsis. By using single-cell RNA sequencing, they ...

Food Sources: Sweet potatoes, carrots, cantaloupe, leafy greens and eggs. Because vitamin A is fat-soluble, it’s best to ...

Researchers at Trinity Biomedical Sciences Institute (TBSI) have found that nanoplastics, which are even smaller than ...

Cambridge scientists built a two-part cancer drug that activates only in tumors with high enzyme levels, showing promise in ...

Biomea Fusion (BMEA) announced the presentation of preclinical data from its investigational menin inhibitor icovamenib in combination with ...

Science writer Mary Roach chronicles both the history and the latest science of body part replacement in her new book. She ...

Despite marijuana’s Schedule I status, which classifies it as having no accepted medical use, hundreds of studies in the past ...

Coya's COYA 303 showed strong immune modulation and reduced inflammation in the brain, supporting its development for ...